Study of the combination of gemcitabine, cetuximab and radiotherapy in patients with head and neck cancer

Trial Profile

Study of the combination of gemcitabine, cetuximab and radiotherapy in patients with head and neck cancer

Recruiting
Phase of Trial: Phase II

Latest Information Update: 25 Sep 2014

At a glance

  • Drugs Cetuximab (Primary) ; Gemcitabine (Primary)
  • Indications Head and neck cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 25 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top